Given a three-dimensional model of a drug’s potential target (the binding site), what is the orientation of the drug candidate molecule that best “fits” (docks onto) this binding site? Structure-based drug design involves the use of …
Read More
Streamline your genomic and multiomic data analysis with DRAGEN on Amazon EC2 F2 instances. Our latest blog post explores the performance benefits of this hardware-accelerated solution, helping you unlock insights faster.
Read More
In this blog post, we’re excited to share how Novo Nordisk, Columbia University and AWS collaborated to create OpenFold3, a state-of-the-art protein structure prediction model, using cost-effective and scalable bioinformatics solutions on …
Read More
In this blog post, we’re excited to share how Novo Nordisk, Columbia University and AWS collaborated to create OpenFold3, a state-of-the-art protein structure prediction model, using cost-effective and scalable bioinformatics solutions on …
Read More
In the race to deliver precision medicine, time is of the essence. Caris Life Sciences, a pioneer in this field, leveraged AWS Batch to build a highly scalable solution that processed hundreds of thousands of genomic samples in record time. …
Read More
Cryogenic electron microscopy (Cryo-EM) allows drug discovery researchers to determine the three-dimensional structures of molecules critical to drug discovery. As Cryo-EM adoption has increased, scientists and IT owners have looked for …
Read More
Curious about running AI-powered protein folding analyses on AWS? Quantori’s new solution makes it easy to test generative models and visualize results in your own cloud environment.
Read the Post on the AWS Blog Channel
Read More
Proteins hold the secrets of life, if only we can study them in sufficient detail. Learn how a team at Max Planck leveraged AWS Spot Instances with Cyclone to run massive GROMACS simulations and push the boundaries of biophysics.
Read More